Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Virent is an industrial biotechnology company that specializes in the conversion of plant-based sugars into renewable fuels and chemicals. The company's proprietary BioForming® technology platform utilizes catalytic chemistry to produce "drop-in" hydrocarbons, including bio-gasoline, jet fuel, and paraxylene, which are molecularly identical to their petroleum-derived counterparts. Virent gained significant industry attention through its partnership with The Coca-Cola Company to develop 100% bio-based PET plastic bottles and its work on sustainable aviation fuel (SAF). Since its acquisition by Marathon Petroleum in 2016, Virent has continued to advance its technology toward commercial-scale production of renewable aromatics and fuels.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Virent.